LBM22
LBM22 is a CDC2-like kinase 2 (CLK2) inhibitor with the IC50 of 3.9 nM. LBM22 has antiproliferative activity and inhibits serine/arginine-rich (SR) protein phosphorylation. LBM22 down-regulates the expression of Wnt-related proteins and anti-apoptotic proteins and can be used for study of non-small cell lung cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C28H22F2N6O2
- Peso molecular:512.51
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Chemical Information
-
Peso molecular 512.51
-
Fòrmula C28H22F2N6O2
-
SMILES
FC1(F)CN(CC2=CN=CC(C3=CC4=C(NN=C4C5=NC(C6=CC=CO6)=C(C7=CC=CO7)N5)C=C3)=C2)CC1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)